Trial Profile

DOS [Dosing Optimization Study]: Open-label, Single-arm, Proof-of-Concept Dosing Study of Afrezza in Adult Subjects 18 Years and Older With Type 1 or Type 2 Diabetes Mellitus

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 19 Sep 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

22 Feb 2023 Results published in the Mannkind media release.
22 Feb 2023 According to Mannkind media release, the oral presentation describing meal challenge results will be presented at the 16th International Conference on Advanced Technologies & Treatment for Diabetes (ATTD) in Berlin from February 22nd-25th.
10 Nov 2022 According to MannKind Corporation Media Release, data showing effects of the three treatment groups on glycemic control are being readied for publication and are planned to be presented at a diabetes conference in 2023.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com